Progressive Cervix Cancer
1 clinical trials · Condition
◉ Watch Progressive Cervix Cancer
| Record | Firm | Date |
|---|---|---|
| Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer (NCT04068753) | University of Oklahoma | 2020-02-26 |
Track Progressive Cervix Cancer automatically
Every clearance here is in the API, with alerts when new ones post.